• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Selvita S.A.

Headquarters: Krakow, Poland
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Boguslaw Sieczkowski, MBA
Number Of Employees: 969
Enterprise Value: $269,531,504
PE Ratio: -105.06
Exchange/Ticker 1: Warsaw:SLV
Exchange/Ticker 2: N/A
Latest Market Cap: $169,919,571

BioCentury | Feb 16, 2019
Emerging Company Profile

NodThera: Inhibiting the inflammasome for NASH

How NodThera is tackling NASH with NLRP3 inflammasome inhibitors
BioCentury | Jan 18, 2019
Targets & Mechanisms

Exploring 3-D genomic white space

How 3-D chromatin structures open up a higher level of gene regulation control
BioCentury | Jun 29, 2018
Finance

Nailing down NLRP3

Why investors backed $37M series A for inflammasome play NodThera
BioCentury | Sep 20, 2017
Distillery Therapeutics

Inflammation

BioCentury | Aug 9, 2017
Distillery Therapeutics

Neurology

BioCentury | May 3, 2017
Distillery Therapeutics

Gastrointestinal

BioCentury | Mar 31, 2017
Company News

Selvita, Menarini deal

Items per page:
1 - 10 of 22